Morgan Stanley’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Buy |
|
|||||
|
2025
Q1 | $39K | Sell |
|
|||||
|
2024
Q4 | $2.38M | Buy |
|
|||||
|
2024
Q3 | $103K | Sell |
|
|||||
|
2024
Q2 | $174K | Sell |
|
|||||
|
2024
Q1 | $445K | Sell |
|
|||||
|
2023
Q4 | $1.46M | Buy |
|
|||||
|
2023
Q3 | $1.4M | Buy |
|
|||||
|
2023
Q2 | $756K | Sell |
|
|||||
|
2023
Q1 | $2.83M | Sell |
|
|||||
|
2022
Q4 | $4.38M | Buy |
|
|||||
|
2022
Q3 | $5.9M | Sell |
|
|||||
|
2022
Q2 | $10.8M | Sell |
|
|||||
|
2022
Q1 | $20.7M | Buy |
|
|||||
|
2021
Q4 | $6.85M | Sell |
|
|||||
|
2021
Q3 | $11M | Buy |
|
|||||
|
2021
Q2 | $17M | Sell |
|
|||||
|
2021
Q1 | $17.9M | Buy |
|
|||||
|
2020
Q4 | $11.5M | Buy |
|
|||||
|
2020
Q3 | $6.36M | Buy |
|
|||||
|
2020
Q2 | $3.4M | Buy |
|
|||||
|
2020
Q1 | $1.15M | Sell |
|
|||||
|
2019
Q4 | $2.17M | Sell |
|
|||||
|
2019
Q3 | $1.58M | Buy |
|
|||||
|
2019
Q2 | $690K | Sell |
|
|||||
|
2019
Q1 | $960K | Buy |
|
|||||
|
2018
Q4 | $804K | Sell |
|
|||||
|
2018
Q3 | $1.69M | Sell |
|
|||||
|
2018
Q2 | $1.84M | Sell |
|
|||||
|
2018
Q1 | $1.98M | Buy |
|
|||||
|
2017
Q4 | $671K | Buy |
|
|||||
|
2017
Q3 | $675K | Buy |
|
|||||
|
2017
Q2 | $281K | Sell |
|
|||||
|
2017
Q1 | $718K | Sell |
|
|||||
|
2016
Q4 | $964K | Buy |
|
|||||
|
2016
Q3 | $175K | Buy |
|
|||||
|
2016
Q2 | $35K | Sell |
|
|||||
|
2016
Q1 | $192K | Buy |
|
|||||
|
2015
Q4 | $257K | Sell |
|
|||||
|
2015
Q3 | $1.41M | Buy |
|
|||||
|
2015
Q2 | $837K | Sell |
|
|||||
|
2015
Q1 | $1.77M | Buy |
|
|||||
|
2014
Q4 | $1.79M | Sell |
|
|||||
|
2014
Q3 | $1.7M | Buy |
|
|||||
|
2014
Q2 | $2.11M | Buy |
|
|||||
|
2014
Q1 | $469K | Sell |
|
|||||
|
2013
Q4 | $2.74M | Buy |
|